Síndrome de hiperestimulación ováricafactores de riesgo, fisiopatología y manifestaciones clínicas

  1. Clara Sáez Ibarra
  2. Irene Ruiz Adelantado
  3. Lorenzo Alarcón García
Revue:
Revista Sanitaria de Investigación

ISSN: 2660-7085

Année de publication: 2024

Volumen: 5

Número: 6

Type: Article

DIALNET GOOGLE SCHOLAR lock_openAccès ouvert editor

D'autres publications dans: Revista Sanitaria de Investigación

Résumé

Ovarian hyperstimulation syndrome is an iatrogenic complication derived from ovarian stimulation treatments performed with assisted reproduction techniques. Although the etiology is not known, it is known that the presence of chorionic gonadotropin is necessary for the symptoms to occur. The pathophysiology is based on the increase in vascular permeability that occurs, generating a leak of fluid into the third space. There are a series of factors that increase the risk of developing the condition, in the face of which a series of measures must be carried out for prevention. In this regard, metformin and cabergoline have shown some evidence of efficacy in terms of reducing the incidence of severe forms. The symptoms are highly variable, from mild symptoms without systemic repercussions to severe forms that entail dysfunction of vital organs, including multiple organ failure.

Références bibliographiques

  • Sociedad Española de Ginecología y Obstetricia. Prevención y manejo del síndrome de hiperestimulación ovárica (2017). Prog Obstet Ginecol 2018;61(4):408-414.
  • Síndrome de Hiperestimulaciónovàrica. Guía de práctica clínica. Sociedad Española de Fertilidad. 2012.
  • The Prevention of Ovarian Hyperestimulation Syndrome. Clinical Practice Guideline. J Obstet Gynaecol Can 2014;36(11):1024–1033.
  • ASRM Guideline. Prevention and treatment of moderate and severe ovarian hyperestimulation syndrome. Fertility and Sterility .2016:106.
  • Nastri CO, Teixeira DM, Moroni RM, Leitão VM, Martins WP. Ovarian hyperstimulation syndrome: pathophysiology, staging, prediction and prevention. UltrasoundObstetGynecol. 2015 Apr;45(4):377-93.
  • Azcona B., Campo G., Zabaleta J. Síndrome de hiperestimulación ovárica. Anales Sis San Navarra. 2009 [citado 2024 Mayo 05] ; 32 (Suppl 1):19-27.
La source de données: Dialnet